Lisata Therapeutics Inc expected to post a loss of 90 cents a share - Earnings Preview

Lisata Therapeutics

09/11/2022 01:52

* Lisata Therapeutics Inc  LSTA.OQ   LSTA.O  is expected
to show
no change in quarterly revenue when it reports  results on
November 10. 
    * 
    * ​Refinitiv's mean analyst estimate for Lisata Therapeutics
Inc
is for a loss of 90 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lisata
Therapeutics Inc is $30​, above​ its last closing price
of $3.75. ​​​

This summary was machine generated November 9 at 01:52 GMT.  All
figures in US dollars  unless otherwise stated